|Bid||31.13 x 900|
|Ask||52.57 x 900|
|Day's Range||33.50 - 39.40|
|52 Week Range||27.50 - 73.00|
|Beta (5Y Monthly)||1.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 23, 2022 - Feb 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.13|
Subscribe to Yahoo Finance Plus to view Fair Value for APLSLearn more
Ipswich, MA, based Investment company Ipswich Investment Management Co., Inc. (Current Portfolio) buys GXO Logistics Inc, Stag Industrial Inc, Moderna Inc, Ares Capital Corp, Coca-Cola Europacific Partners PLC, sells Church & Dwight Co Inc, Apellis Pharmaceuticals Inc, International Business Machines Corp, Sanofi SA, ISHARES TRUST during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Ipswich Investment Management Co., Inc..
Investment company Sippican Capital Advisors (Current Portfolio) buys Coterra Energy Inc, DaVita Inc, Physicians Realty Trust, Ncino Inc, Triumph Bancorp Inc, sells TriState Capital Holdings Inc, Central Securities Corp, Adobe Inc, Vulcan Materials Co, Berkshire Hathaway Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Sippican Capital Advisors.
WALTHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity awards to one new employee with a grant date of January 3, 2022, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 0 Inducement Stock Incentive Plan) and material to the employee’s acceptance of employment with the company.